Discover our new oral solid dose (OSD) development capabilities at our Bend, Oregon site.
Poorly soluble compounds often demonstrate lower bioavailability, which can reduce the efficacy of the drug substance or product. Quadrant 2™ is a diagnostic tool for early development, which allows us to see in-silico predictions of formulations.
The results of this diagnostic tool can save time and costs by avoiding trial and error approaches because we can quickly provide a solution to enhance solubility:
Download this fact sheet to learn more about the Quadrant 2™ predictive platform.